Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
4(40%)
Results Posted
50%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_3
1
10%
Ph not_applicable
6
60%
Ph phase_2
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

4

trials recruiting

Total Trials

10

all time

Status Distribution
Active(5)
Completed(2)
Terminated(1)
Other(2)

Detailed Status

unknown2
Completed2
Recruiting2
Active, not recruiting2
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
4
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (12.5%)
Phase 31 (12.5%)
N/A6 (75.0%)

Trials by Status

terminated110%
unknown220%
completed220%
not_yet_recruiting110%
recruiting220%
active_not_recruiting220%

Recent Activity

4 active trials
Showing 5 of 10
not_yet_recruitingnot_applicable

Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial

NCT07526545
active_not_recruitingnot_applicable

Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules

NCT06638398
recruitingnot_applicable

INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis

NCT07398690
active_not_recruitingnot_applicable

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

NCT00542373
recruitingnot_applicable

Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules

NCT05229341
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07526545Not Applicable

Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial

Not Yet Recruiting
NCT06638398Not Applicable

Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules

Active Not Recruiting
NCT07398690Not Applicable

INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis

Recruiting
NCT00542373Not Applicable

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

Active Not Recruiting
NCT05229341Not Applicable

Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules

Recruiting
NCT00964275Not Applicable

Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein

Completed
NCT00390364Phase 2

Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy

Terminated
NCT00553124Phase 3

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

Unknown
NCT00535834

Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154

Completed
NCT01064674

Cardiovascular Evaluation Before Renal Transplantation

Unknown

All 10 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
10